Home / Technology / Liver Doc Questions Ranveer Allahbadia on Temple Wearable
Liver Doc Questions Ranveer Allahbadia on Temple Wearable
8 Nov
Summary
- The Liver Doc questions Ranveer Allahbadia's endorsement due to investor interest.
- Allahbadia is an angel investor in Deepinder Goyal's Temple wearable startup.
- Temple wearable faces criticism over scientific claims and methodology.
Dr. Cyriac Abby Philips, also known as The Liver Doc, has publicly questioned Ranveer Allahbadia's endorsement of Deepinder Goyal's Temple wearable. Philips specifically asked Allahbadia to disclose his financial interests in the health-tech startup, noting that Allahbadia is an angel investor. This comes after Allahbadia defended the Temple project amidst growing criticism over its scientific validity.
Allahbadia, also known as BeerBiceps, had argued on X that the Temple device should not be dismissed without sufficient evidence, pointing to Goyal's personal investment and an advisory board with scientists from Harvard and Boston University. Priced at approximately Rs 85,000, the Temple wearable claims to track BrainFlow and Entropy, measures related to brain activity and bodily functions.
However, The Liver Doc has raised serious concerns about the device's ability to accurately measure blood flow in the brain, its scientific methodology, and the absence of clinical studies validating its benefits. Philips has previously compared the Temple device to pseudoscience, drawing parallels with other controversial health products.
